• 1
    Atkinson RL. Naloxone decreases food intake in obese humans. J Clin Endocrinol Metab 1982;55: 196198.
  • 2
    Baker IA, Jarrett RJ. Diurnal variation in the blood-sugar and plasma-insulin response to tolbutamide. Lancet 1972;1: 945947.
  • 3
    Bergman RN, Beard JC, Chen M. The minimal modeling method. Assessment of insulin sensitivity and B-cell function in vivo: Clake WL, et al., eds. Clinical Methods. Vol 2: New York, NY: John Wiley & Sons Inc; 1986: 1534.
  • 4
    Bolli GB, Gerich JE. The “dawn phenomenon” - a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus. N Engl J Med 1984; 310: 746750.
  • 5
    Bray GA, Gallagher TF Jr. Manifestations of hypothalamic obesity in man: A comprehensive investigation of eight patients and a review of the literature. Medicine 1975;54: 301330.
  • 6
    Bray GA. Syndromes of hypothalamic obesity in man. Pediatric Ann 1984;13(7): 525536.
  • 7
    Bray GA, York DA. Hypothalamic and genetic obese experimental animals: an autonomic and endocrine hypothesis. Physiol Rev 1979;59: 719789.
  • 8
    Bray GA, York DA, Fisler JS. Experimental obesity: a homeostatic failure due to defective nutrient stimulation of the sympathetic nervous system. Vit Horm 1989;45: 1125.
  • 9
    Bruni J., Watkins W., Yen SSC. β-endorphin in human pancreas. J Clin Endocrinol Metab 1979;49: 649651.
  • 10
    Campbell PJ, Bolli GB, Cryer PE, et al. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion. N Engl J Med 1985; 312: 14731479.
  • 11
    Carroll KF, Nestel PL. Diurnal variation in glucose tolerance and in insulin secretion in man. Diabetes 1973;22: 333348.
  • 12
    Fukushima M., Tokunaga K., Lupien J., et al. Dynamic and static phases of obesity following lesions in PVN and VMH. Am J Physiol 1987;253 (Regulatory Integrative Comp. Physiol. 22): R523R529.
  • 13
    Genazzani AR, Facehinetti F., Petraglia F., et al. Hyperendoxphinemia in obese children and adolescents. J Clin Endocrinol Metab 1986; 623640.
  • 14
    Gibson T., Jarrett R. Diurnal variation in insulin sensitivity. Lancet 1972;1: 947948.
  • 15
    Giugliano D., Salvatore T., Cozzolino D., et al. Sensitivity to β-endorphin as a cause of human obesity. Metabolism 1987;36: 974978.
  • 16
    Giugliano D. Morphine, opioid peptides and pancreatic islet function. Diabetes Care 1984;7: 9298.
  • 17
    Givens JR, Kurtz BR, Kitabchi AE, et al. Reduction of Hyperinsulinemia and insulin resistance by opiate receptor blockade in the polycystic ovary syndrome with acanthosis nigricans. J Clin Endocrinol Metab 1987;64: 377382.
  • 18
    Givens JR, Wiedemann E., Anderson RN, et al. β-endorphin and β-lipotropin plasma levels in hirsute women: correlation of body weight. J Clin Endocrinol Metab 1980;50: 975976.
  • 19
    Grandison S., Guidotti A. Stimulation of food intake by muscimol and β-endorphin. Neuropharmacology 1977;16: 533536.
  • 20
    Jarrett RJ. Rhythms in insulin and glucose: In: Krieger DT. ed.. Endocrine Rhythms. New York, NY: Raven Press; 1979: 247258.
  • 21
    Jarrett RJ, Baker IA, Keen H., et al. Diurnal glucose tolerance, blood sugar, and plasma insulin levels in the morning, afternoon, and evening. Br Med J 1972; 1: 199201.
  • 22
    Jeanrenaud B. An hypothesis on the etiology of obesity: dysfunction of the central nervous system as a primary cause. Diabetologia 1985;28: 502513.
  • 23
    Krieger DG. Ventromedial hypothalamic lesions abolish food shifted circadian adrenal and temperature rhythmicity. Endocrinology 1980;106: 649654.
  • 24
    Kyriakides M., Silverstone T., Jeffcoate N., et al. Effect of naloxone on hyperphagia in Prader-Willi syndrome. Lancet 1980;1(8173): 876877.
  • 25
    Lee A., Bray GA, Kletzky O. Nocturnal growth hormone secretion does not affect diurnal variations in arginine and glucose-stimulated insulin secretion. Metabolism 1991;40: 181186.
  • 26
    Lee A., Ader, M., Bray GA, Bergman, RN. Diurnal variation in glucose tolerance: cyclic suppression of insulin action and insulin secretion in normal weight, but not obese subjects. Diabetes 1992;41: 750759.
  • 27
    Luiten PGM, Horst JG, Steffens AB. The hypothalamus, intrinsic connections and outflow pathways to the endocrine system in relation to the control of feeding and metabolism. Prog Neurobiol 1987;28: 154.
  • 28
    Margules DL, Moisset B., Lewis M., et al. β-endorphin is associated with overeating in genetically obese mice (ob/ob) and rats (fd/fa). Science 1978;202: 988991.
  • 29
    Martin JB. Plasma growth hormone response to hypothalamic and extrahypothalamic electric stimulation. Endocrinology 1972;91: 107115.
  • 30
    Morgan CR, Lazarow A. Immunoassay of insulin: two antibody system: plasma insulin levels of normal, subdiabetic and diabetic rats. Diabetes 1963;12: 115126.
  • 31
    Nagai KT, Nishio H., Nakagawa H., et al. Effect of bilateral lesions of the suprachiasmatic nuclei on the circadian rhythm of food-intake. Brain Res 1978;142: 384389.
  • 32
    Rusak B., Zucker I. Neural regulation of circadian rhythms. Physiol Rev 1979;59: 449526.
  • 33
    Sakaguchi T., Takahashi M., Bray GA. Effect of the suprachiasmatic nucleus on food intake and sympathetic function in rats. J Clin Invest 1988;32: 282286.
  • 34
    Schmidt MI, Lin QX, Gwynne JT, et al. Fasting early morning rise in peripheral insulin: evidence of the dawn phenomenon in nondiabetics. Diabetes Care 1984;7: 3235.
  • 35
    Sclafani A. Animal models of obesity: Classification and characterization. Int J Obes 1984;8: 491508.
  • 36
    Whichelow MJ, Sturge RA, Keen H., et al. Diurnal variation in response to intravenous glucose. Br Med J 1974;1: 488491.
  • 37
    Zinimet PS, Wall JR, Rome R., et al. Diurnal variation in glucose tolerance: associated changes in plasma insulin, growth hormone, and nonesterified fatty acids. Br Med J 1974;1: 485491.
  • 38
    Zipf WB, Bernstson GG. Characteristics of abnormal food-intake patterns in children with Prader-Willi syndrome and study of effects of naloxone. Am J Clin Nutr 1987;46: 277281.